1.39

6.51% 0.085

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $1.39, with a volume of 68,768. It is up +6.51% in the last 24 hours and down -29.44% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Previous Close:

$1.305

Open:

$1.27

24h Volume:

68,768

Relative Volume:

0.02

Market Cap:

$6.23M

Revenue:

$72,100

Net Income/Loss:

$-3.60M

P/E Ratio:

-1.1681

EPS:

-1.19

Net Cash Flow:

$-3.37M

1W Performance:

-0.71%

1M Performance:

-29.44%

6M Performance:

-4.14%

1Y Performance:

-11.46%

1-Day Range:

$1.24

$1.40

1-Week Range:

$1.20

$1.5195

52-Week Range:

$0.77

$4.50

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1167)

Industry

Biotechnology (674)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO SILO PHARMA INC	1.71	17.96M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	0.1935	408.35M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.50	372.90M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	0.4399	278.60M	0	0	0	0.00
SHMD Schmid Group N V	2.79	120.14M	0	0	0	0.00
JUNE Dhandho Junoon Etf	4.0439	52.60M	0	0	0	0.00

Silo Pharma Inc Stock (SILO) Latest News

Feb 18, 2025

Silo Files Provisional Patent For SPC-15 Combination Treatment To Target Stress-Induced Disorders - Nasdaq

Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment - The Manila Times

Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with - GlobeNewswire

Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for ... - The Bakersfield Californian

Feb 18, 2025

Revolutionary Mental Health Treatment Patent: Silo Pharma's Dual-Action SPC-15 Shows Promising Results - StockTitan

Feb 18, 2025

Feb 12, 2025

Silo Pharma reports positive early data on pain treatment implant By Investing.com - Investing.com Nigeria

Feb 12, 2025

Feb 11, 2025

Silo Pharma Announces Positive Initial Pharmacokinetic, - GlobeNewswire

Feb 11, 2025

Silo Pharma reports positive early data on pain treatment implant - Investing.com

Feb 11, 2025

SILO’s valuation metrics: A comprehensive analysis - US Post News

Feb 11, 2025

Silo Pharma's SP-26 Shows Promising Initial Safety And Absorption Data For Pain Relief - Nasdaq

Feb 11, 2025

Silo Pharma Reports Positive Safety Update from SP-26 Ketamine Implant Study with No Serious Side Effects Observed - Nasdaq

Feb 11, 2025

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 - The Bakersfield Californian

Feb 11, 2025

Revolutionary Pain Treatment: SILO's Ketamine Implant Aces Initial Safety Tests - StockTitan

Feb 11, 2025

Feb 04, 2025

Monitoring SILO Pharma Inc (SILO) after recent insider movements - Knox Daily

Feb 04, 2025